Management of heart failure in the elderly: Recommendations from the French Society of Cardiology (SFC) and the French Society of Gerontology and Geriatrics (SFGG)

Journal of Nutrition, Health and Aging

Volumn 10, Issue 5, 2006, Pages 434-444

  Komajda, M ^a   Hanon, O ^b   Aupetit, J F ^c   Benetos, A ^c   Berrut, G ^d   Emeriau, J P ^e   Friocourt, P ^f   Galinier, M ^g   De Groote, P ^h   Jondeau, G ⁱ   Jourdain, P ^f   Forette, F ^f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Paris Descartes University   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f NONE

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; LISINOPRIL; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL SUCCINATE; NEBIVOLOL; NITRIC ACID DERIVATIVE; OMEPRAZOLE; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

AGING; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COMORBIDITY; CREATININE CLEARANCE; DIETARY INTAKE; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; ECHOCARDIOGRAPHY; ELDERLY CARE; FRANCE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VALVE REPLACEMENT; HOSPITALIZATION; HUMAN; HYPOKALEMIA; HYPONATREMIA; HYPOVOLEMIA; KIDNEY DYSFUNCTION; LABORATORY TEST; LIFESTYLE; MEDICAL SOCIETY; MORTALITY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 33845194246     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Delahaye F, de Gevigney G, Gaillard S, Cheneau E. Epidemiology and economic impact of heart failure in France. Arch Mal Coeur Vaiss 1998;91:1307-14
2. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:6A-13A
3. Wang R, Mouliswar M, Denman S, Kleban M. Mortality of the institutionalized old hospitalized with congestive heart failure. Arch Intern Med 1998;158:2464-8
4. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin DL, Krumholz HM. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003;41:217-23.
5. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, Marino EK, Lyles M, Cushman M, Enright PL. Cardiovascular Health Study Research Group. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001;87:413-9
6. Tresch D The clinical diagnosis of heart failure in older patients. JAGS 1997;45:1128-3
7. Rockwood K. Acute confusion in elderly medical patients. J Am Geriatr Soc 1989;37:150-4
8. Gambassi G, Forman DE, Lapane KL, Mor V, Sgadari A, Lipsitz LA, Bernabei R. Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group. Am Heart J 2000; 139:85-93
9. Beresin EV. Delirium in the elderly. J Geriatr Psychiatry Neurol 1988;1:127-43
10. Levkoff SE, Evans DA, Liptzin B et al. Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 1992;152:334-40
11. Fulop G, Strain JJ, Stettin G. Congestive heart failure and depression in older adults: clinical course and health services use 6 months after hospitalization. Psychosomatics 2003;44:367-73
12. Guck TP, Elsasser GN, Kavan MG, Barone EJ. Depression and congestive heart failure. Congest Heart Fail 2003;9:163-9
13. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-33
14. Dimsdale JE, Hackett TP. Effect of denial on cardiac health and psychological assessment. Am J Psychiatry 1982;139:1477-80
15. Skoog I, Lemfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-5
16. Gottdiener JS, McClelland RL, Marshall R et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002;137:631-9
17. Lien CT, Gillespie ND, Struthers AD, McMurdo ME. Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail 2002;4:91-8
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
19. Maisel AS, Krishnaswamy P, Nowak RM et al. Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7
20. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999;20:421-8
21. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997;45:968-74
22. Campbell AJ, Buchner DM. Unstable disability and the fluctuations of frailty. Age Ageing 1997;26:315-8
23. Applegate WB, Miller ST, Graney MJ, Elam JT, Burns R, Akins DE. A randomized, controlled trial of a geriatric assessment unit in a community rehabilitation hospital. N Engl J Med 1990;322:1572-8
24. Buchner DM, Wagner EH. Preventing frail health. Clin Geriatr Med 1992;8:1-17
25. Winograd CH, Gerety MB, Chung M, Goldstein MK, Dominguez F Jr, Vallone R. Screening for frailty: criteria and predictors of outcomes. J Am Geriatr Soc 1991;39:778-84
26. Folstein M.F., Folstein S.E., Mc Hugh P.R. "Mini-Mental TEST". A pratical method for grading the cognitive state of patients for the clinician. J Psychiat Research 1975;12: 189-98
27. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186
28. Katz A, Ford AB, Moskowitz RW et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. J Am Med Assoc 1963;185:914-919
29. Barberger-Gateau P, Dartigues JF, Letenneur L. Four Instrumental Activities of Daily Living Score as a predictor of one-year incident dementia. Age Ageing 1993;22:457-6330.
30. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002;18:737-57
31. Struthers AD, Anderson G, Donnan PT, MacDonald T. Social deprivation increases cardiac hospitalisations in chronic heart failure independent of disease severity and diuretic non-adherence. Heart 2000;83:12-6
32. Swedberg K, Cleland J, Dargie H et al. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.: Eur Heart J. 2005 ;26:1115-40.
33. Howard PA, Dunn MI. Agressive diuresis for severe heart failure in the elderly. Chest 2001;119:807-10
34. Neuberg GW, Miller AB, O'Connor CM and al: PRAISE investigators. Prospective Randomized Amlodipine Survival Evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002;144:31-8
35. Van Kraaij DJ, Jansen RW, Bouwels LH, Gribnau FW, Hoefnagels WH. Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function. Am J Cardiol 2000;85:1461-6
36. Walma EP, Hoes AW, van Dooren C, Prins A, van der Does E. Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial. Brit Med J 1997;315:464-8
37. Mehagnoul-Schipper DJ, Colier WN, Hoefnagels WH, Verbeugt FW, Jansen RW. Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients ≥70 years of age with heart failure. Am J Cardiol 2002;90,596-600
38. Rosholm JU, Andersen Ranberg K, Himmelstrup B, Skjelbo E, Christen K, Gram LF. Hyponatrimia in very old nonhospitalised people: association with drug use. Drugs Aging 2002;19:685-93
39. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717
40. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321
41. Juurlink DN, Mamdani MM, Lee DS et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.: N Engl J Med. 2004;351:543-51.
42. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35
43. Conn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10
44. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302
45. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med 1992;327:685-91
46. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77
47. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8
48. Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:p1670-6
49. Ryden L, Armstrong PW, Cleland JGF, et al. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J 2000;21:1967-78
50. Ahmed A, Maisiak R, Allman RM, DeLong JF, Farmer R. Heart failure mortality among older Medicare beneficiaries: association with left ventricular function evaluation and angiotensin-converting enzyme inhibitor use. South Med J 2003;96:124-9
51. Havranek EP, Abrams F, Stevens E, Parker K. Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors. Arch Int Med 1998;158:2024-8
52. Johnson D, Jin Y, Quan H, Cujec B. Beta-blockers and angiotensin- converting enzyme inhibitors/receptors blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta. Canada. J Am Coll Cardiol 2003;42:1438-45
53. Gattis WA, Larsen RL, Hasselblad V, Bart BA, O'Connor CM. Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? Am Heart J 1998;136:43-8
54. Komajda M, Follath F, et al. The Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment. Eur Heart J 2003;24:464-74
55. The large state peer review organization consortium. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Int Med 1997;158:97-8
56. Forman DE, Chander RB, Lapane KL, Shah P, Stoukides J. Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure. J Am Geriatr Soc 1998;46:1385-6
57. Ahmed A, Allman RM, DeLong JF, Bodner EV, Howard G. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients. South Med J 2002;95:703-10
58. Howard PA, Shireman TI, Dhingra A, Ellerbeck EF, Fincham JE. Patterns of ACE inhibitor use in elderly Medicaid patients with heart failure. Am J Geriat Cardiol 2002;11:287-94
59. Anionelli Incalzi R, Pedone C, Pahor M, et al. Trends in prescribing ACE-inhibitors for congestive heart failure in elderly people. Aging Clin Exp Res 2002;14:516-21
60. Echemann M, Zannad F, Briançon S, et al. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: The EPICAL study. Am Heart J 2000;139:624-31
61. Chen YT, Wang Y, Radford MJ, Krumholz HM. Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure. Am Heart J 2001;141:410-7
62. Ahmed A, Kiefe CI, Allman RM, Sims RV, DeLong JF. Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications. J Am Geriatr Soc 2002;50:1659-66
63. US Carvedilol Heart Failure Study Group, M. Packer, M.R. Bristow, J.N. Cohn et al., The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355
64. CIBIS-II Investigators and Committees, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13
65. MERIT-HF Study Group, Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007
66. M. Packer, M.B. Fowler, E.B. Roecker et al., Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002;106:2194-2199
67. Jullien G, Fraboulet JY, Poncelet P, Avierinos C, Sebaoun A, Gallois H, Cohen-Solal A. Registry of cardiac insufficiency in cardiology. Arch Mal Coeur Vaiss 2001;94:1351-1356
68. Flather MD, Shibata MC, Coats AJ et al. SENIORS Investigators; Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005 ;26:215-25.
69. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003;362:772-776
70. Pfeffer MA, McMurray JJ, Velazquez EJ et al; Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003;349:1893-1906
71. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767-771
72. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 2003;362:777-781
73. Rich MW, McSherry F, Williford WO, Yusuf S, for the Digitalis Investigation Group. Effect of age on mortality, hospitalization and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol 2001;38:806-13
74. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G. A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatric Society. Eur Heart J 2000;21:763-9
75. Fuster V, Ryden L E, Asinger R. W. et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing an Electrophysiology. Eur. Heart J. 2001; 22: 1852-923.
76. Collet JP, Montalescot G, Choussat R, Lison L, Ankri A. Enoxaparin in unstable angina patients with renal failure. Int J Cardio 2001 80:81-2
77. Tresh DD, Troup PJ, Thakur RK, et al. Comparison of efficacy of automatic implantable cardioverter defibrillator in patients older and younger than 65 years of age. Am J Med 1991;90:717-24
78. Saksena S, Prakash A, Shen WK. A multicenter study of cardiac procedures and implantables defibrillators in the elderly and very elderly. Pacing Clin Electrophysiol 2001;24:553
79. Saksena S, Mathew P, Giorgberidze I, Krol RB, Kaushik R. Implantable defibrillator therapy for the elderly. Am J Geriatr Cardiol 1998;7:11-3
80. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L: Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure.: N Engl J Med. 2005;352:1539-49.
81. Cleland JG, Swedberg K, Follath F et al. The EuroHeart Survey programme. A survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of cardiology. Eur Heart J 2003;24:442-63
82. Conaway DG, House J, Bandt K, Hayden L, Borkon AM, Spertus JA. The elderly: health status benefits and recovery of function one after coronary artery bypass surgery. J Am Coll cardiol 2003; 42: 1421-6
83. Sedrakyan A, Vaccarino V, Paltiel AD, Eleteriades JA, Mattera JA, Lin Z, Krumholz HM. Age does not limit quality of life improvement in cardiac valve surgery. J Am Coll Cardiol 2003; 42: 1208-14
84. Bachelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7.472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol 2000;36:723-30
85. Alexander KP, Anstrom KJ, Muhlbaier LH, Grosswald RD, Smith PK, Jones RH. Outcomes of cardiac surgery in patients aged > 80 years. Results from the national cardiovascular network. J Am Coll Cardiol 2000;35:731-8
86. Stuck AE, Aronow HU, Steiner A, Alessi CA, Bula CJ, Gold MN, Yuhas KE, Nisenbaum R, Rubenstein LZ, Beck JC. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl J Med 1995,333:1184-9
87. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995,333:1190-5
88. McAlister FA, Lawson FM, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 2001,110:378-84
89. Grady KL, Dracup K, Kennedy G, Moser DK, Piano M, Stevenson LW, Young JB. Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation 2000,102:2443-56
90. Erhardt LR, Cline CM. Organisation of the care of patients with heart failure. Lancet 1998,352:15-8
91. Gibbs JS, McCoy AS, Gibbs LM, Rogers AE, Addington-Hall JM. Living with and dying from heart failure: the role of palliative care. Heart 2002,88:36-9
92. Ward C. The need for palliative care in the management of heart failure. Heart 2002,87: 294-8
93. Athavale NV. Palliative care is an important aspect of heart failure management. Age Ageing 2003,32:117-891.
94. Krumholz HM, Phillips RS, Hamel MB et al. Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation 1998,98:648-55
95. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-326.